AVACTA GROUP PLC ORD GBP0.10AVACTA GROUP PLC ORD GBP0.10AVACTA GROUP PLC ORD GBP0.10

AVACTA GROUP PLC ORD GBP0.10

No trades
See on Supercharts

AVCT fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Avacta Group Plc engages in the provision of Affimer reagents for licensing into third-party research and diagnostic products, and creates new Affimer medicines for development in-house and licensing to large pharmaceutical companies. It operates through the Life Sciences and Animal Health segments. The Life Sciences segment offers custom Affimers for reagents and diagnostics, drug and biomarker discovery in biotech research and development. The Animal Health segment includes tools and contract services to assist diagnosis of conditions in animals to enable faster treatment for veterinarians. The company was founded by Alastair MacLaughlin Smith, Simon Webster, and Kurt Justin Baldwin in 2003 and is headquartered in Leeds, the United Kingdom.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

AVCT does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company